Health Care & Life Sciences » Pharmaceuticals | vTv Therapeutics Inc.

vTv Therapeutics Inc. Cl A | Mutual Funds

Mutual Funds that own vTv Therapeutics Inc. Cl A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Franklin Biotechnology Discovery Fund
317,100
2.77%
0
0.02%
03/31/2018
APO Medical Opportunities Institutionell
99,000
0.87%
0
0.05%
06/29/2018
Vanguard Extended Market Index Fund
94,591
0.83%
0
0%
07/31/2018
Bridgeway Ultra Small Company Market Fund
60,000
0.52%
0
0.02%
12/31/2017
Tredje AP Fonden
32,934
0.28%
0
0%
06/30/2017
JPMorgan Insurance Trust - Small Cap Core Portfolio
31,900
0.28%
11,300
0.02%
03/31/2018
Fidelity Nasdaq Composite Index
25,511
0.22%
0
0%
07/31/2018
Fidelity Spartan Extended Market Index Fund
25,196
0.22%
0
0%
07/31/2018
iShares Micro Cap ETF
16,236
0.14%
0
0%
09/06/2018
CREF Stock Account
15,064
0.13%
0
0%
03/31/2018

About vTv Therapeutics

View Profile
Address
4170 Mendenhall Oaks Parkway
High Point North Carolina 27265
United States
Employees -
Website http://www.vtvtherapeutics.com
Updated 07/08/2019
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical holding company. The firm engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer.